These ASX 200 shares could rise 20% to 40%

Analysts are tipping these shares to deliver market-beating returns over the next 12 months.

| More on:
A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are on the lookout for some big returns in 2025, then it could pay to listen to what analysts are saying about the ASX 200 shares in this article.

That's because they have been named as buys and tipped to rise at least 20% from current levels. Here's what you need to know about them:

Treasury Wine Estates Ltd (ASX: TWE)

This wine giant's shares came under pressure last week following the release of its half year results.

Although its result itself was relatively strong, its guidance for the full year disappointed the market.

The team at Morgans believes this is a buying opportunity for investors. In response to its results, the broker has reaffirmed its add rating on the ASX 200 share with a reduced price target of $13.43.

Based on its current share price of $10.83, this implies potential upside of 24% for investors over the next 12 months. In addition, the broker is forecasting a 3.7% dividend yield in FY 2025, which boosts the total potential return to almost 28%.

Deep Yellow Ltd (ASX: DYL)

If you have a high tolerance for risk and looking for exposure to the uranium industry, then Morgans thinks that Deep Yellow could be the way to do it.

Its analysts recently visited Deep Yellow's Tumas project in Namibia ahead of its Final Investment Decision next month. It appears confident that a positive decision will be made and is recommending the uranium developer as a buy.

The note reveals that Morgans has put a speculative buy rating and $1.73 price target on the ASX 200 share. Based on its current share price of $1.25, this suggests that upside of almost 40% between now and this time next year.

CSL Ltd (ASX: CSL)

Finally, Goldman Sachs thinks that CSL could be an ASX 200 share with major upside potential.

While the biotechnology giant's half year results disappointed the market, the team at Goldman Sachs saw enough to remain bullish. Particularly given the strength of the key CSL Behring business.

As a result, the broker appears to see last week's share price weakness as a buying opportunity for investors.

In response to the result, the broker has reaffirmed its buy rating with a trimmed price target of $318.40. Based on the latest CSL share price of $256.90, this implies potential upside of 24% for investors over the next 12 months.

Motley Fool contributor James Mickleboro has positions in CSL and Treasury Wine Estates. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Goldman Sachs Group. The Motley Fool Australia has recommended CSL and Treasury Wine Estates. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman wine tasting in a bottle shop.
Value Investing

ASX value shares rated as broker buys

The sell-off has opened the window for value plays to shine.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Broker Notes

Lovisa shares down more than 30% from all-time high. Time to snap them up?

Analysts have given their verdict on this popular stock. Here's what they are saying.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Brickworks shares down 25% in 1 year. Is this a buying opportunity?

Is this blue chip a bargain buy? Let's see what one leading broker thinks.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

These ASX 200 stocks could rise 25% to 40% after the market selloff

Analysts believe these shares have the potential to generate big returns over the next 12 months.

Read more »

Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should you buy the dip on the CSL share price?

Has the market sell-off created an opportunity to buy this mega ASX 200 blue chip at an attractive price?

Read more »